SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457395-10-000001
Filing Date
2010-09-29
Accepted
2010-09-29 18:40:32
Documents
1
Period of Report
2010-09-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3698
  Complete submission text file 0001457395-10-000001.txt   5673
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address
Karan Shashi K. (Reporting) CIK: 0001457395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 101097612